OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.

Aydinlar, ELİF; Dikmen, PİNAR; Kosak, Seda; Kocaman, AYŞE

doi:10.1186/s10194-017-0723-4

OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.

Copy For Citation

Aydinlar E. , Dikmen P. , Kosak S., Kocaman A.

The journal of headache and pain, vol.18, no.1, pp.23, 2017 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 18 Issue: 1
Publication Date: 2017
Doi Number: 10.1186/s10194-017-0723-4
Title of Journal : The journal of headache and pain
Page Numbers: pp.23

Abstract

Background: OnabotulinumtoxinA (OnabotA) is considered effective in in patients with chronic migraine (CM) who failed on traditional therapies. This study was designed to evaluate the effect of OnabotA injection series on migraine outcome, negative emotional states and sleep quality in patients with CM.